Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation

Leukemia. 2005 Jul;19(7):1262-5. doi: 10.1038/sj.leu.2403752.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Cohort Studies
  • Follow-Up Studies
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Piperazines / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Remission Induction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stem Cell Transplantation*
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate